Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2010 3
2011 4
2012 9
2013 7
2014 11
2015 23
2016 21
2017 29
2018 12
2019 4
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 26494691

105 results
Results by year
Filters applied: . Clear all
Page 1
Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression.
Biller A, Badde S, Nagel A, Neumann JO, Wick W, Hertenstein A, Bendszus M, Sahm F, Benkhedah N, Kleesiek J. Biller A, et al. AJNR Am J Neuroradiol. 2016 Jan;37(1):66-73. doi: 10.3174/ajnr.A4493. Epub 2015 Oct 22. AJNR Am J Neuroradiol. 2016. PMID: 26494691 Free article.
MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A, Zimmermann M, Kitzwögerer M, Oberndorfer S, Rössler K, Dörfler A, Buchfelder M, Heinz G. Stadlbauer A, et al. Radiology. 2017 Jun;283(3):799-809. doi: 10.1148/radiol.2016161422. Epub 2016 Dec 13. Radiology. 2017. PMID: 27982759
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.
Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N. Delfanti RL, et al. J Neurooncol. 2017 Dec;135(3):601-609. doi: 10.1007/s11060-017-2613-7. Epub 2017 Sep 4. J Neurooncol. 2017. PMID: 28871469 Free PMC article.
Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.
Li X, Strasser B, Jafari-Khouzani K, Thapa B, Small J, Cahill DP, Dietrich J, Batchelor TT, Andronesi OC. Li X, et al. Radiology. 2020 Mar;294(3):589-597. doi: 10.1148/radiol.2020191529. Epub 2020 Jan 7. Radiology. 2020. PMID: 31909698
Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics.
Bahrami N, Hartman SJ, Chang YH, Delfanti R, White NS, Karunamuni R, Seibert TM, Dale AM, Hattangadi-Gluth JA, Piccioni D, Farid N, McDonald CR. Bahrami N, et al. J Neurooncol. 2018 Sep;139(3):633-642. doi: 10.1007/s11060-018-2908-3. Epub 2018 Jun 2. J Neurooncol. 2018. PMID: 29860714 Free article.
Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S, Zou T, Eberhart CG, Villalobos MAV, Heo HY, Zhang Y, Wang Y, Wang X, Yu H, Du Y, van Zijl PCM, Wen Z, Zhou J. Jiang S, et al. Magn Reson Med. 2017 Sep;78(3):1100-1109. doi: 10.1002/mrm.26820. Epub 2017 Jul 16. Magn Reson Med. 2017. PMID: 28714279 Free PMC article.
Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi T, Sugiyama T, Ohira M, Kageyama H, Yokoi S, Sakaida T, Hasegawa Y, Setoguchi T, Itami M. Iuchi T, et al. Brain Tumor Pathol. 2018 Apr;35(2):71-80. doi: 10.1007/s10014-018-0309-0. Epub 2018 Feb 22. Brain Tumor Pathol. 2018. PMID: 29470683
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, Tominaga T. Kawaguchi T, et al. J Neurooncol. 2016 Sep;129(3):505-514. doi: 10.1007/s11060-016-2201-2. Epub 2016 Jul 11. J Neurooncol. 2016. PMID: 27401154
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Kickingereder P, Sahm F, Radbruch A, Wick W, Heiland S, Deimling Av, Bendszus M, Wiestler B. Kickingereder P, et al. Sci Rep. 2015 Nov 5;5:16238. doi: 10.1038/srep16238. Sci Rep. 2015. PMID: 26538165 Free PMC article.
105 results
Jump to page
Feedback